home / stock / ears / ears news

EARS News and Press, Auris Medical Holding AG From 09/13/19

Stock Information
Company Name: Auris Medical Holding AG
Stock Symbol: EARS
Market: NASDAQ
Menu
EARS EARS Quote EARS Short EARS News EARS Articles EARS Message Board
Get EARS Alerts

News, Short Squeeze, Breakout and More Instantly...
EARS - Auris Medical Receives FDA and EMA Guidance for Keyzilen® Late-Stage Clinical Development Program

Hamilton, Bermuda, Sept. 13, 2019 (GLOBE NEWSWIRE) -- Auris Medical Holding Ltd. (NASDAQ: EARS), a clinical-stage company dedicated to developing therapeutics that address important unmet medical needs in neurotology and central nervous system disorders, today announced that it has obtained...
EARS - Auris Medical nabs new patent in U.S. and Europe

The USPTO has issued a notice of allowance to Auris Medical Holding's (NASDAQ: EARS ) patent application entitled “Pharmaceutical Composition Comprising Betahistine” (U.S. Patent Application No. 15/887,388). More news on: Auris Medical Holding Ltd., Healthcare stocks news, ...

EARS - Auris Medical Announces Notices of Allowance for U.S. and European Patent Applications Covering Intranasal Betahistine

Hamilton, Bermuda, Sept. 11, 2019 (GLOBE NEWSWIRE) -- Auris Medical Holding Ltd. (NASDAQ: EARS), a clinical-stage company dedicated to developing therapeutics that address important unmet medical needs in neurotology and central nervous system disorders, today announced that the United Stat...

EARS - Auris Medical Announces Appointment of New Chief Financial Officer

Hamilton, Bermuda, Sept. 04, 2019 (GLOBE NEWSWIRE) -- Auris Medical Holding Ltd. (NASDAQ: EARS), a clinical-stage company dedicated to developing therapeutics that address important unmet medical needs in neurotology and central nervous system disorders, today announced the appointment of E...
EARS - Auris Medical Announces Formation of Scientific Advisory Board for Tinnitus Programs

Hamilton, Bermuda, Aug. 26, 2019 (GLOBE NEWSWIRE) -- Auris Medical Holding Ltd. (NASDAQ: EARS), a clinical-stage company dedicated to developing therapeutics that address important unmet medical needs in neurotology and central nervous system disorders, today announced the formation of a Sc...

EARS - Auris Medical Holding Ltd. (EARS) CEO Thomas Meyer on Q2 2019 Results - Earnings Call Transcript

Auris Medical Holding Ltd. (EARS) Q2 2019 Results Earnings Conference Call August 15, 2019, 08:00 AM ET Company Participants Thomas Meyer - CEO Hernan Levett - CFO Conference Call Participants Presentation Operator Good morning, and welcome to Auris Medical's Conferen...

EARS - Auris Medical reports 1H results

Auris Medical (NASDAQ: EARS ): 1H GAAP EPS of -CHF1.66. More news on: Auris Medical Holding Ltd., Earnings news and commentary, Healthcare stocks news, , Read more ...

EARS - Auris Medical Provides Business Update and Reports First Half 2019 Financial Results

Hamilton, Bermuda, Aug. 15, 2019 (GLOBE NEWSWIRE) -- Enrollment of first patient in TRAVERS Phase 2 trial with AM-125 in acute vertigo Enrollment completed in Phase 1b trial with AM-201 in antipsychotic-induced weight gain Relocation to Bermuda to gain corporate flexibility, reduce co...

EARS - OSTK, NBIX among premarket gainers

Sigma Labs (NASDAQ: SGLB ) +19%  to work with airbus to deploy PrintRite3D rapid test and evaluation program More news on: Sigma Labs, Inc., Valeritas Holdings, Inc., RingCentral, Inc., Stocks on the move, Read more ...

EARS - Auris Medical Announces Randomization of First Patient in AM-125 Phase 2 Trial in Acute Vertigo

Hamilton, Bermuda, July 30, 2019 (GLOBE NEWSWIRE) -- Auris Medical Holding Ltd. (NASDAQ: EARS), a clinical-stage company dedicated to developing therapeutics that address important unmet medical needs in neurotology and central nervous system disorders, today announced that the first patien...
Previous 10 Next 10